Langue par pays Mathématiques Sciences Sciences sociales Entreprise Ingénierie Humanités Histoire
  1. Sciences
  2. Médecine
  3. Cancérologie
FACULTE DE MEDECINE HENRI WAREMBOURG Prise en charge
FACULTE DE MEDECINE HENRI WAREMBOURG Prise en charge
Factors contributing to the time taken to consult with
Factors contributing to the time taken to consult with
Factors associated with self-perceived burden to the primary
Factors associated with self-perceived burden to the primary
Extended Criteria Donors: The Case for Liver System Malignancy
Extended Criteria Donors: The Case for Liver System Malignancy
Exploring the link between MORF4L1 and risk of breast cancer Open Access
Exploring the link between MORF4L1 and risk of breast cancer Open Access
Examen prostate
Examen prostate
Examen clinique sein
Examen clinique sein
Evolution de l`épidémiologie du cancer de la prostate depuis 20 ans
Evolution de l`épidémiologie du cancer de la prostate depuis 20 ans
Evolution de la fiche RCP
Evolution de la fiche RCP
Everolimus Plus Exemestane Versus Everolimus or Bent Ejlertsen, Guy Jerusalem,
Everolimus Plus Exemestane Versus Everolimus or Bent Ejlertsen, Guy Jerusalem,
Etude exploratoire du coût socio-économique de la pollution de l`air
Etude exploratoire du coût socio-économique de la pollution de l`air
Etude de proximologie FACE : Femme atteinte d`un cancer du sein
Etude de proximologie FACE : Femme atteinte d`un cancer du sein
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology
ESDO GI 2015 Slide Deck.ppt
ESDO GI 2015 Slide Deck.ppt
ESDO GI 2014 Slide Deck.ppt
ESDO GI 2014 Slide Deck.ppt
ESDO GI 2013 Slide Deck.ppt
ESDO GI 2013 Slide Deck.ppt
ESDO ASCO June_2016 slides CRC_English ppt
ESDO ASCO June_2016 slides CRC_English ppt
ESDO ASCO 2015 Slides Non-CRC 22Jun.ppt
ESDO ASCO 2015 Slides Non-CRC 22Jun.ppt
ESDO ASCO 2015 Slides CRC 22Jun15.ppt
ESDO ASCO 2015 Slides CRC 22Jun15.ppt
ERA-NET: Aligning national/regional translational cancer research programmes and activities TRANSCAN-2
ERA-NET: Aligning national/regional translational cancer research programmes and activities TRANSCAN-2
EPITHELIAL TO MESENCHYMAL TRANSITION IN MAMMARY TISSUE AND ANTI METASTASIS THERAPY
EPITHELIAL TO MESENCHYMAL TRANSITION IN MAMMARY TISSUE AND ANTI METASTASIS THERAPY